Study titleStudy titleeeedada FReSH-83099-en kolsi Rami Study titleStudy titleeeedada Study acronym FReSH-83099-en aaaaaaaaaaa azdzadzadazd zadzadadzadazd First name of the principal investigator111111111 LAST NAME OF THE PRINCIPAL INVESTIGATOR1111111111 First name of the principal investigator 2222222 LAST NAME OF THE PRINCIPAL INVESTIGATOR 22222222222 First name of the principal investigator FIRST NAME OF THE PRINCIPAL INVESTIGATOR AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE) CENTRE PSYCHOTHERAPIQUE DE NANCY (CPN) AG2R AGIRC-ARRCO (UGRR) France Recherche en Santé Humaine (FReSH) AG2R AGIRC-ARRCO (UGRR) null First name of the principal investigator;LAST NAME OF THE PRINCIPAL INVESTIGATOR First name of the principal investigator111111111;LAST NAME OF THE PRINCIPAL INVESTIGATOR1111111111 First name of the principal investigator 2222222;LAST NAME OF THE PRINCIPAL INVESTIGATOR 22222222222 First name of the team leade1111111111;LAST NAME OF THE TEAM LEADE111111111111 First name of the team leader2222222222;LAST NAME OF THE TEAM LEADER22222222222 First name of the principal investigator;FIRST NAME OF THE PRINCIPAL INVESTIGATOR ANSM CNIL CESREES CPP Other zzz fezfez ef zfz efe zef e ffff Addiction medicine Allergology Venereology Other Ramifenazone Ramipril Ramucirumab Socio-demographic and economic determinants Socio-demographic and economic determinants: Employment Environmental determinants Environmental determinants: Air quality Healthcare system determinants Healthcare system determinants: Access to care Behavioral determinants Behavioral determinants: Addiction Biological determinants Biological determinants: Genetic predisposition Other Other medical specialty, details Other determinants, details Study objectives Study summary * France Åland islands Auvergne Rhône-Alpes Bourgogne Franche-Comté Pays de la Loire Provence - Alpes - Côte d'Azur Individus Other Other Prenatal Infant, Newborn (birth to 28 days) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Inclusion Criteri Exclusion Criteria Clinical data Paraclinical data (non-biological) Paraclinical data (non-biological) : Imaging Biological data Environmental / exposure data Behavioral data Economic data Participant-reported health data Other zdadzadzad zadazdazdadazd Other form of gouvernance, detailsOther form of gouvernance, detailsOther form of gouvernance, detailsOther form of gouvernance, detailsOther form of gouvernance, detailsOther form of gouvernance, details zadazdzadad dzadazdzadzad ddddddddddddddddddddddddd zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz Retrospective longitudinal jyrjrjrtjt Complete enumeration (including consecutive recruitment) Probability Probability: Simple random Non-probability Non-probability: Availability (convenience or opportunity sampling) Mixed probability and non-probability Other Administrative database (employees pupils students etc.) Disease and death registry Other [1000-10000[ individuals Converting or copying information into a structured record Experiment / trial Field experimentation (clinical or public health intervention) Interview with the participant (including clinical) Measurements and tests Educational tests/assessment of health knowledge (literacy, self-management, interpretation of medical information, etc.) Observation (clinical or behavioural) Recording (audio, video, electrophysiological, imaging) Self-administered questionnaire Other jtrjrj rtjrtjtr Passive participant monitoring Clinical source Clinical record Other afzafzafazf3 afzafafa3 Data enrichment through cross-referencing Medico-administrative database Research data Other Observational Study Observational Study Cohort study Monitoring by contact with the participant (mail, e-mail, telephone etc.) Monitoring by participant visit to the investigation center Other rrrrrrrrrrrrrrambod Unknown eeeeeeeeeeeeeeeeeeee Metadata-only access dzadzazzzzzzzzzzzzz eeeeeeeeeeeeeeeee rrrrrrrrrrrrrrrrrrrrrrr dzadadzad zzzzzzzzzzzzz zdadzadzadzad;DZADAZDAZDZAD zadadzad dzadzad aaaaaaaaaaaaaaaa dzadzadzad